Literature DB >> 18782865

p21 differentially regulates DNA replication and DNA-repair-associated processes after UV irradiation.

Gaston Soria1, Juliana Speroni, Osvaldo L Podhajcer, Carol Prives, Vanesa Gottifredi.   

Abstract

Although p21 upregulation is required to block cell-cycle progression following many types of genotoxic insult, UV irradiation triggers p21 proteolysis. The significance of the increased p21 turnover is unclear and might be associated with DNA repair. While the role of p21 in nucleotide excision repair (NER) remains controversial, recent reports have explored its effect on translesion DNA synthesis (TLS), a process that avoids replication blockage during S phase. Herein, we analyze the effect of p21 on different PCNA-driven processes including DNA replication, NER and TLS. Whereas only the CDK-binding domain of p21 is required for cell-cycle arrest in unstressed cells, neither the CDK-binding nor the PCNA-binding domain of p21 is able to block early and late steps of NER. Intriguingly, through its PCNA-binding domain, p21 inhibits the interaction of the TLS polymerase, pol eta (pol eta), with PCNA and impairs the assembly of pol eta foci after UV. Moreover, this obstruction correlates with accumulation of phosphorylated H2AX and increased apoptosis. By showing that p21 is a negative regulator of PCNA-pol eta interaction, our data unveil a link between efficient TLS and UV-induced degradation of p21.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18782865     DOI: 10.1242/jcs.027730

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  49 in total

1.  Pattern of expression of p53, its family members, and regulators during early ocular development and in the post-mitotic retina.

Authors:  Linda Vuong; Daniel E Brobst; Anisse Saadi; Ivana Ivanovic; Muayyad R Al-Ubaidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-20       Impact factor: 4.799

Review 2.  Multiple functions of p21 in cancer radiotherapy.

Authors:  Yanbei Kuang; Jian Kang; Hongbin Li; Bingtao Liu; Xueshan Zhao; Linying Li; Xiaodong Jin; Qiang Li
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-05       Impact factor: 4.553

3.  p21 is dispensable for AID-mediated class switch recombination and mutagenesis of immunoglobulin genes during somatic hypermutation.

Authors:  Maryam Shansab; Erik Selsing
Journal:  Mol Immunol       Date:  2011-02-01       Impact factor: 4.407

Review 4.  Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance.

Authors:  Lauren S Waters; Brenda K Minesinger; Mary Ellen Wiltrout; Sanjay D'Souza; Rachel V Woodruff; Graham C Walker
Journal:  Microbiol Mol Biol Rev       Date:  2009-03       Impact factor: 11.056

Review 5.  Y-family DNA polymerases in mammalian cells.

Authors:  Caixia Guo; J Nicole Kosarek-Stancel; Tie-Shan Tang; Errol C Friedberg
Journal:  Cell Mol Life Sci       Date:  2009-04-15       Impact factor: 9.261

6.  A novel function of CRL4(Cdt2): regulation of the subunit structure of DNA polymerase δ in response to DNA damage and during the S phase.

Authors:  Sufang Zhang; Hong Zhao; Zbiegniew Darzynkiewicz; Pengbo Zhou; Zhongtao Zhang; Ernest Y C Lee; Marietta Y W T Lee
Journal:  J Biol Chem       Date:  2013-08-02       Impact factor: 5.157

Review 7.  The identification of translesion DNA synthesis regulators: Inhibitors in the spotlight.

Authors:  A P Bertolin; S F Mansilla; V Gottifredi
Journal:  DNA Repair (Amst)       Date:  2015-05-12

Review 8.  Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase.

Authors:  Courtney G Havens; Johannes C Walter
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

9.  PIDD orchestrates translesion DNA synthesis in response to UV irradiation.

Authors:  E Logette; S Schuepbach-Mallepell; M J Eckert; X H Leo; B Jaccard; C Manzl; A Tardivel; A Villunger; M Quadroni; O Gaide; J Tschopp
Journal:  Cell Death Differ       Date:  2011-03-18       Impact factor: 15.828

Review 10.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.